Net Cash Provided by (Used in) Operating Activities |
-915K |
USD |
-182% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
-86.3M |
USD |
-700% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-95.7M |
USD |
-106% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
50M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
13.4M |
shares |
|
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-183M |
USD |
-492% |
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
5.57M |
USD |
-50.6% |
Q2 2025 |
Q2 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
267K |
USD |
|
Q1 2025 |
Q1 2025 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
Preferred Stock, Shares Authorized |
10K |
shares |
0% |
Q2 2025 |
Q2 2025 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q2 2025 |
Q2 2025 |
Additional Paid in Capital |
187M |
USD |
+311% |
Q2 2025 |
Q2 2025 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
Share-based Payment Arrangement, Expense |
841K |
USD |
|
Q2 2025 |
Q2 2025 |
Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |